Meet In CommonNewsRSS feeds

Local

FDA Doesn't Approve Summit's China-Developed Lung Cancer Drug

Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

Source: Investor's Business Daily

The FDA said Summit Therapeutics' lung cancer drug ivonescimab, developed in China, failed to show a statistically significant survival benefit.

This excerpt comes from the named source. Read the original for the full reporting.

Read the original at Investor's Business Daily

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

Yutori

Yutori 3375 El Camino Real Palo Alto, CA, 94306 US

City guide for Palo Alto, CA

Community Poll

A club's identity belongs partly to its community, not solely to its owners.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

Your coworker's religious holiday means you work the unpopular shift again. Is that fair?

A workplace accommodates religious observances by asking other employees to cover unpopular shifts. One coworker objects that nonreligious commitments can be equally meaningful but receive less formal protection.

Does equal respect require treating every kind of commitment identically?

Explore this quandary